Samjin Pharmaceuticals Co., Ltd. (KRX:005500)

Samjin Pharmaceuticals Revenue

In the year 2022, Samjin Pharmaceuticals had annual revenue of 274.03B KRW with 9.58% growth. Samjin Pharmaceuticals had revenue of 48.92B in the quarter ending September 30, 2013, a decrease of -1.45%. That makes Samjin Pharmaceuticals the 17,240th largest company in the world by revenue and 875th in South Korea.

• Revenue: 274.03B
• Revenue Growth: +45.04%
• P/S Ratio: 0.88
• Revenue / Employee: 467.63M
• Employees: 586
• Market Cap: 240.25B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 268.86B 98.1%
• Overseas 5.17B 1.9%

Fiscal year ended Dec 31, 2022

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	274.03B	23.96B	9.58%
Dec 31, 2021	250.07B	64.37B	34.66%
Dec 31, 2012	185.70B	-16.05B	-7.96%
Dec 31, 2011	201.76B	1.35B	0.67%
Dec 31, 2010	200.41B	35.02B	21.18%

Data Source: S&P Global Market Intelligence Last updated: Nov 14, 2013

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error